Digital Health, Technology & Innovation

Factor 7 Medical Expands Leadership, Enhances MedTech Services

Factor 7 Medical

Following a leadership consolidation and the launch of a strategic growth plan last year, F7 Medical’s executive additions strengthen its expertise in five growth areas essential to successful MedTech commercialization.

Factor 7 Medical (F7M), a leading consulting and advisory group for medical technology companies, is accelerating its expansion with the addition of five seasoned industry veterans. This strategic move enhances F7M’s ability to support start-up companies, growth stage ventures, and established enterprises in achieving their complex commercialization goals.

With expertise spanning the entire MedTech commercialization lifecycle, the expanded leadership team strengthens F7M’s capabilities across five service areas critical for effective and efficient commercialization of medical innovation: product development; regulatory and quality assurance; operations and supply chain management; sales, marketing and reimbursement strategies; and business and capital formation.

The new team members – each with decades of experience across the MedTech commercialization landscape – bring a new level of trusted expertise and exceptional execution to F7M’s global clientele.

  • Justin Rowland
  • Brogan McGuire
  • Matt Otten
  • Kim Frazier
  • Michael Cooper

“These industry veterans power up our ability to provide specialized, fractional expertise to MedTech companies at every stage of growth,” said Dan Sands, Founder and Managing Director of F7M. “With this team’s depth of experience, companies can access senior-level guidance in a flexible, cost-effective model—gaining powerful insights that ensure efficient and successful commercialization strategies.”

“F7M was founded on the principle that MedTech companies need the right expertise at the right time to achieve meaningful growth,” added Bill Phillips, Chairman of the Board. “This expansion enables us to serve our clients with even greater depth, ensuring they have the insight, experience, and execution power necessary to bring groundbreaking medical innovations to market.”

Discover the latest trends and insights—explore the Business Insights Journal for up-to-date strategies and industry breakthroughs!

Related posts

QIAGEN Opens New Data Center to Boost Bioinformatics in APAC

Business Wire

Viventium Enhances Scheduling with Open Shift Management

GlobeNewswire

Ria Health Secures Growth Capital to Expand AUD Treatment

Business Wire